PYC

4.00%

13.0¢ pyc therapeutics limited

thanks hottod!

First 4 Last

Share
Profile

Follow
travelbug2

6,545 Posts.

326

10/09/19

15:30

Post #: 40368873
Share

Originally posted by hottod: ↑

TB, from my recall, someone asked if the Rare Paediatric Disease Priority Review Voucher program was something that PYC might benefit from. After all, PYC is developing a therapy for rare inherited retinal disease and, typically, these diseases begin to impact in childhood. It was agreed that the program could be relevant to PYC and could be highly valuable.

The program is something that is also relevant to NEU, which I also hold, so I’ve patched together the following information from previous postings on that forum.

Under the FDA's Rare Paediatric Disease Priority Review Voucher program, which came into operation in its present form in 2014, a drug sponsor may request a priority review voucher from the FDA when submitting an NDA for a rare paediatric disease indication. If the FDA agrees to grant the request, the drug sponsor receives a priority review voucher if its drug receives marketing approval.

The priority review voucher can be redeemed by the drug sponsor to obtain priority review for a subsequent marketing application for a different drug. “Priority review” means that the FDA will review the drug within 6 months instead of the standard 10 months. Alternatively, the voucher can be sold to the highest bidder.

PRVs have been sold for as much as $350 million (4 years ago). Three PRVs have been sold during the past year, each of which has returned between $80 and $105 million.

Although rare paediatric PRVs don’t expire, the voucher program itself is due to expire in October 2020. After that date, only drugs already designated as rare paediatric treatments and which receive marketing approval by October 2022 can receive a voucher.

My thinking is that, unless the program is extended, PYC would be unlikely to make the cut-off date for the program.

https://www.rdmag.com/article/2019/02/understanding-fdas-priority-review-voucher-system

Expand

thanks hottod!

PYC Price at posting: 4.7¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 4 more messages in this thread...

First 4 Last

Add PYC (ASX) to my watchlist

(20min delay)
Last 13.0¢		Change 0.005(4.00%)		Mkt cap ! $606.5M

Open	High	Low	Value	Volume
12.5¢	13.0¢	12.0¢	$415.6K	3.255M

Buyers (Bids)

No.	Vol.	Price($)
4	112056	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	127118	2

View Market Depth

No.	Vol.	Price($)
4	112056	0.125
17	1109619	0.120
12	1226909	0.115
10	527452	0.110
11	1201829	0.105

Price($)	Vol.	No.
0.130	166	1
0.135	806167	10
0.140	803540	4
0.145	450000	2
0.150	845000	5

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PYC (ASX) Chart

thanks hottod!

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Immutep reports strong response rate from immunotherapies treating carcinomas

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

thanks hottod!

Top Stories

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Immutep reports strong response rate from immunotherapies treating carcinomas

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News